Skip to main content

Table 2 Propensity score logistic models of receiving at least one ASCT and of receiving consolidation phase treatment

From: Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma

 

Receiving at least one ASCT

Receiving consolidation phase treatment

 

Coeff.

S.E.

P > |z|

95 %

C.I.

Coeff.

S.E.

P > |z|

95 %

C.I.

Age > 50 years

0.2192

0.2005

0.2740

-0.1738

0.6122

-1.1036

0.3268

0.0010

-1.7442

-0.4631

Male sex

-0.3034

0.1756

0.0840

-0.6476

0.0408

0.1046

0.1739

0.5470

-0.2361

0.4454

HB ≤ 10.5 g/dL

-0.1751

0.1809

0.3330

-0.5296

0.1795

0.0556

0.1851

0.7640

-0.3072

0.4183

Plts ≤ 150 x109/L

-0.1085

0.2592

0.6750

-0.6166

0.3995

0.3935

0.3059

0.1980

-0.2060

0.9930

Crea > 1.2 μmol/dL

0.0577

0.2220

0.7950

-0.3774

0.4927

0.0155

0.2167

0.9430

-0.4092

0.4402

LDH > 190 U/L

0.3097

0.2220

0.1630

-0.1254

0.7448

0.3123

0.2309

0.1760

-0.1403

0.7648

ISS > 1

0.2584

0.1864

0.1660

-0.1070

0.6238

0.1231

0.1770

0.4870

-0.2238

0.4700

IgA isotype

0.0031

0.2062

0.9880

-0.4011

0.4073

-0.1299

0.2136

0.5430

-0.5485

0.2887

Del(13q)

0.0375

0.1765

0.8320

-0.3086

0.3835

-0.0420

0.1722

0.8070

-0.3795

0.2954

T(4;14)

-0.1485

0.2099

0.4790

-0.5599

0.2628

0.3715

0.2321

0.1100

-0.0835

0.8264

Del(17p)

-0.2640

0.3039

0.3850

-0.8597

0.3317

0.4939

0.4040

0.2220

-0.2979

1.2858

Arm A

0.2628

0.1672

0.1160

-0.0649

0.5906

0.0036

0.1657

0.9830

-0.3212

0.3284

CR at induction

    

0.1073

0.2476

0.6650

-0.3781

0.5926

Constant

0.7531

0.2990

0.0120

0.1670

1.3392

1.3012

0.4762

0.0060

0.3678

2.2345